HomeCompaniesProfile

Talus Bio

Discovering drugs that target the DNA regulome 


Company Size

11 - 50 employees

Year Founded

2020


About Talus Bio

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Founders & Key People

Alex Federation

Alex Federation

Founder, Talus Bio

Lindsay Pino

Lindsay Pino

Founder, Talus Bio

Share This Profile

More Companies

SwiftSku

Management and analytics software for convenience stores

hypcloud

A tech-enabled commercial mortgage broker. hypcloud allows property…

Journey

No code platform for sales to tell better stories and win more deals.

CostCertified

The platform for buying, selling and managing residential construction

Titan

Titan is an award-winning wealth manager with a mission to increase…

CreatorOS - Questbook

User data verification across Employment, Academic Creds, Retail…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.